Works matching IS 22965270 AND DT 2023 AND VI 46 AND IP 10
Results: 9
Front & Back Matter.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 10, p. 1, doi. 10.1159/000534508
- Publication type:
- Article
Sacituzumab govitecan: Zulassungserweiterung HR+/HER2– mBC.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 10, p. 442, doi. 10.1159/000534221
- Publication type:
- Article
Neue AML-Therapie für IDH1-Mutation zugelassen.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 10, p. 441, doi. 10.1159/000534220
- Publication type:
- Article
PharmaNews.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 10, p. 444, doi. 10.1159/000534218
- Publication type:
- Article
Society Bulletins.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 10, p. 449, doi. 10.1159/000534144
- Publication type:
- Article
No Survival Differences among Germ-Cell Cancer Patients from Urban and Rural Areas.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 10, p. 433, doi. 10.1159/000533505
- By:
- Publication type:
- Article
The Leucine-Rich α2-Glycoprotein-1 Levels in Patients with Multiple Myeloma.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 10, p. 415, doi. 10.1159/000532042
- By:
- Publication type:
- Article
Assessment and Evaluation of Psychosocial Distress in Outpatients with Cancer at a University Hospital in Germany.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 10, p. 424, doi. 10.1159/000531888
- By:
- Publication type:
- Article
Erratum.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 10, p. 438, doi. 10.1159/000530178
- Publication type:
- Article